US says Pakistan to attend bilateral talks in Washington but gives no details
The comment came in response to a question at a news briefing about whether Washington's push for direct communication between India and Pakistan — such as on the Indus Waters Treaty — would also apply to more contentious issues like Kashmir.
Pakistan and India had a four-day military standoff in May that ended with a US-brokered ceasefire. Washington later announced that both countries had agreed to meet at a neutral venue to discuss outstanding issues.
Pakistan welcomed the proposal, but India, which has long opposed third-party involvement, rejected it.
'We have Pakistan who is going to be here for a bilat, and I'll be participating in that,' State Department spokesperson Tammy Bruce said during the briefing, without elaborating on the schedule or the agenda. 'I'm looking forward to that as well.'
Bruce did not directly answer the question on Kashmir, instead offering a general comment about addressing difficult issues.
The briefing came weeks after a rare one-on-one lunch hosted by former President Donald Trump for Pakistan's military chief, Field Marshal Asim Munir, at the White House on June 18. No civilian Pakistani officials were present at the meeting.
Trump later credited both Munir and Indian Prime Minister Narendra Modi for 'acting responsibly' and preventing a potential regional catastrophe.
India has denied any US role in the ceasefire, calling it a bilateral decision between New Delhi and Islamabad, though Trump has continued to claim credit for stopping the conflict.
On Tuesday, he reiterated separately that he 'stopped the recent war' between the two countries and claimed five planes were shot down during the fighting.
While political channels between Washington and Islamabad have reactivated in recent weeks, the two sides are also engaged in trade talks after Trump imposed 29 percent 'reciprocal tariffs' on Pakistan in April.
Finance Minister Muhammad Aurangzeb, who is currently in Washington, said both countries are working to shift their relationship from one focused on trade to one anchored in long-term investment.
Speaking after meetings with US Commerce Secretary Howard Lutnick and US Trade Representative Jamieson Greer, Aurangzeb said the two sides had identified priority sectors including minerals, mining, artificial intelligence and cryptocurrency regulation.
He also hinted at forthcoming 'leadership-level' announcements in the coming days.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab News
38 minutes ago
- Arab News
Divorced daughters entitled to father's pension, rules Pakistan's top court
ISLAMABAD: Pakistan's top court on Wednesday ruled that divorced daughters are entitled to their father's pension irrespective of whether their divorce occurred before or after his death, calling for a review of pension regulations that it said were built on patriarchal assumptions and negative stereotypes about women. The 10-page verdict was authored by Justice Ayesha Malik, who upheld a Sindh High Court ruling in favor of a woman named Sorath Fatima, the daughter of a deceased employee of Sindh's Road and Transport Department. After Fatima's father passed away in 2002, her mother received his pension until she also died in 2012. As an unmarried daughter, Fatima initially received the pension, which was ceased by the provincial government after she got married. However, following her divorce in August 2022, Fatima requested the resumption of the pension, which was rejected by the Sindh government. It issued a circular that stated that a daughter who got divorced after her father's demise is not entitled to his pension. Fatima challenged the decision at the Larkana bench of the Sindh High Court, which ruled in her favor. The Sindh government challenged the high court's decision at the Supreme Court, which dismissed the appeal and said that a divorced daughter's right to pension is not dependent on the timing of her divorce. 'We find that the [Sindh government's] circular, which imposes restrictions unsupported by the Act or the Rules, is void ab initio, unconstitutional, and of no legal effect,' the judgment read. It added that the timing of the pensioner's death cannot lawfully be used to extinguish a surviving daughter's right to claim the pension. 'Accordingly, this civil petition, having no force, is dismissed and leave refused,' the verdict read. The judgment said it is deeply concerning, in the context of family pension, that the admissibility of pension to a surviving daughter continues to depend entirely on her marital status. The judgment added that this dependency model revealed that there was a systematic bias that treats a daughter as a dependent, with her financial dependency shifting from parent to spouse. 'This assumption not only perpetuates the stereotypical mindset about women being dependent members within the family structure but also fails to recognize women as individuals or autonomous individuals who may have the capacity to be financially independent,' the judgment read. The verdict added that women have independent rights and are autonomous and should be entitled to family pension where financial needs are established. The court said as a party to the Convention on the Elimination of All Forms of Discrimination Against Women (CEDAW), Pakistan is required to abolish discriminatory laws and practices that impair women's enjoyment of rights on an equal footing with men. The Supreme Court noted that it was important to revisit the law surrounding pensions in Pakistan. 'The Rules should be reconsidered to remove marital status as a condition for entitlement,' it said. 'What we require is a need-based and dignity-affirming framework,' the judgment added. 'COMMENDABLE JUDGMENT' Women's rights activists welcomed the ruling as a progressive step toward dismantling patriarchal norms, saying it reinforces divorced women's right to financial security and reflects a growing judicial sensitivity to gender equality. 'I appreciate the Supreme Court's decision, as granting a divorced woman entitlement to her father's pension can help her lead a dignified life and achieve financial stability,' Farzana Bari, a prominent rights activist and academic, told Arab News. Another rights activist, Samar Minallah, said the ruling would make a significant difference in advancing the rights of women in Pakistan. She added that the ruling reinforces the idea that a daughter remains an integral part of her family, similar to a son. 'The ruling recognizes the financial rights of women, ensuring they are not left destitute, once widowed or divorced after the father's death,' Minallah noted.
Arab News
an hour ago
- Arab News
Pakistan says India's statement on alleged Kashmir attackers ‘replete with fabrications'
ISLAMABAD: Pakistan's foreign office on Wednesday rejected Indian Home Minister Amit Shah's statement claiming New Delhi had killed all three militants involved in the Pahalgam attack, whom he said were allegedly Pakistani nationals, as ' replete with fabrications.' Shah told parliamentarians during a debate on Tuesday that three militants involved in the April 22 attack in Indian-administered Kashmir's Pahalgam town had been killed in a joint operation by the military, paramilitary and police on the outskirts of Srinagar. Shah had also said that all three alleged attackers were Pakistani nationals. Gunmen opened fire on tourists in Pahalgam on April 22, killing 26 in total. India blamed Islamabad for supporting the attack, which Pakistan denied. The attack started a four-day conflict between India and Pakistan in which over 70 people were killed on both sides of the border. 'The account given by the Indian Home Minister is replete with fabrications, leading to serious questions about its credibility,' the Pakistani foreign office said. 'Is it a mere coincidence that the alleged perpetrators of the Pahalgam Attack were killed at the start of the Lok Sabha debate?' The foreign office said India did not avail Prime Minister Shehbaz Sharif's offer of a transparent inquiry into the Pahalgam attack, saying that it instead chose 'the path of belligerence and aggression.' The foreign office also rejected Delhi's assertion that it had established a 'new normal' in bilateral relations with Pakistan by carrying out strikes against alleged 'terrorist' camps in the country in May. 'As we have already shown through our resolute actions in May 2025, we shall forcefully counter any future aggression,' the statement said. 'For us, the only 'normal' in bilateral relations is respect for sovereignty and territorial integrity, and adherence to the principles and purposes of the UN Charter.' The foreign office concluded by saying that Pakistan remains a responsible state committed to peace and regional stability. He said Islamabad wanted to pursue a 'meaningful dialogue' for the resolution of all outstanding issues between the two nations, including that of the disputed Kashmir territory. India and Pakistan, both nuclear-armed neighbors, have gone to war thrice since 1947 after gaining independence from British colonial rule. Two out of these wars have been over the territory of Kashmir. Both claim the territory in full but administer only parts of it. India accuses Pakistan of arming and funding Kashmir militants, which Islamabad denies and says New Delhi fuels militancy in Balochistan and Khyber Pakhtunkhwa (KP) provinces.
Al Arabiya
an hour ago
- Al Arabiya
FDA vaccine chief leaving agency after less than three months
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech companies, patient groups, and conservative allies of President Donald Trump. Dr. Vinay Prasad did not want to be a distraction and was stepping down from his role as the FDA's top vaccine regulator to spend more time with his family, a spokesperson for the Department of Health and Human Services said in a statement late Tuesday. Two people familiar with the situation told The Associated Press that Prasad was ousted following several recent controversies. The people spoke on condition of anonymity to discuss internal personnel matters. Prasad joined the FDA in May after years as an academic researcher at the University of California, San Francisco, where he frequently criticized the FDA's approach to drug approvals and COVID-19 vaccines. His contrarian approach appeared to match FDA Commissioner Marty Makary, who repeatedly praised Prasad's work and intellect. But in recent weeks, Prasad became a target of conservative activists, including Laura Loomer, who flagged Prasad's past statements criticizing Trump and praising liberal independent Senator Bernie Sanders. 'How did this Trump-hating Bernie Bro get into the Trump admin???' Loomer posted on X last week. Prasad also attracted scrutiny for his handling of a recent safety issue surrounding the only approved gene therapy for Duchennes muscular dystrophy. Under his direction, shipments of the therapy were briefly halted after a series of patient deaths, then resumed late Monday following vocal pushback from families of boys with the fatal muscle-wasting disorder. Prasad has long been skeptical of the therapy and other muscular dystrophy drugs sold by the drugmaker Sarepta Therapeutics. As an academic, Prasad gained prominence by attacking the FDA for being too lenient in its standards for approving cancer drugs and other new therapies. That approach is at odds with Trump's Republican supporters, who generally favor speedier approvals and unfettered access to experimental treatments. During Trump's first term, he signed the 'Right to Try' law, a largely symbolic piece of legislation that won popular support from conservatives seeking to give dying patients expanded access to unproven drugs. Prasad's decision to pause Sarepta's therapy was criticized last week by a columnist and the editorial board of The Wall Street Journal. Separately, Prasad's division issued rejection letters this month to three small biotech firms seeking approval for new gene therapies. Prasad's predecessor in the role, Dr. Peter Marks, oversaw a steep rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of patients' genetic code. Prasad has been an outspoken critic of Marks' leadership at FDA, which included overseeing the approval of the first COVID vaccines and therapies.
